Tesla’s UK new car sales dropped sharply by over 45% year-on-year in May, according to preliminary figures from research group New AutoMotive. The U.S. electric vehicle maker sold just 1,758 units last month, compared to 3,244 during the same period in 2023.
The decline comes as Tesla faces mounting competition in the electric vehicle (EV) market and growing public criticism of CEO Elon Musk’s political stance, particularly his alignment with far-right ideologies in Europe. This shift in public sentiment appears to be impacting Tesla’s brand appeal across key European markets.
Despite the drop, Tesla (NASDAQ:TSLA) maintained its position as the top-selling battery electric vehicle (BEV) brand in Britain for the year to date. The company’s strong overall performance earlier in the year has helped it stay ahead of rivals, even as May figures suggest waning momentum.
The broader UK auto market showed resilience, with total new car registrations increasing by 4.3% to 144,098 units in May. Battery electric vehicle sales rose significantly—up 28% compared to a year earlier—highlighting continued consumer interest in EVs.
Meanwhile, Chinese automaker BYD (SZ:002594) made substantial gains, more than doubling its UK sales to 1,388 units. This growth underscores the rising influence of Chinese EV brands in Western markets, posing a stronger challenge to incumbents like Tesla.
As EV adoption accelerates and political perceptions weigh on brand loyalty, Tesla may need to recalibrate its public image and pricing strategies to defend its leadership position in the competitive UK electric vehicle sector.


Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle 



